13.30500 EUR
0.17
1.26%
Last update Dec 15, 7:31 PM CET
Main market
Day range
13.30500
13.40500
Previous close
13.47500
Open
13.40000
Access this stock data via API
Subscribe
Aurinia Pharmaceuticals Inc.
13.31
0.17
1.26%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 200.4M 175.5M 134.0M 45.6M
Cost of revenue 24.1M 14.1M 5.7M 1.1M
Gross profit 176.3M 161.4M 128.4M 44.5M
Operating expense
Research & development 17.7M 49.6M 45.0M 51.1M
Selling general and admin 146.6M 195.0M 196.4M 173.5M
Other operating expenses -3.7M 8.4M -1.5M 574K
Operating income 15.7M -91.7M -111.5M -180.7M
Non operating interest income
Income 14.5M 17.0M 5.1M 529K
Expense 4.1M 2.8M 0 0
Other income expense -19.7M
Pretax income 6.3M -77.5M -106.4M -180.2M
Tax provision 1.4M 551K 1.8M 760K
Net income 4.9M -78.0M -108.2M -181.0M
Basic EPS 0.0 -0.5 -0.8 -1.4
Diluted EPS 0.0 -0.5 -0.8 -1.4
Basic average shares 121.9M 150.1M 147.7M 134.6M
Diluted average shares 121.9M 150.1M 147.7M 134.6M
EBITDA 46.7M -63.0M -103.6M -177.4M
Net income from continuing op. 4.9M -78.0M -108.2M -181.0M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 39 minutes

14:20
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).